Latest news
Silence Therapeutics’ Divesiran Hits Phase II Goal, Sets Up Phase III PV Trial - Yahoo FinanceYahoo Finance · Tue, 11 Aug 2026 05:01:00 GMTTour de France Femmes, stage eight: Vollering sets up dramatic finale as riders clash over alleged blocking - The New York TimesThe New York Times · Sat, 08 Aug 2026 19:40:02 GMTELVN: Strong Phase 1 results and FDA alignment set up ENABLE-2 trial, with $895M cash runway into 2030 - TradingViewTradingView · Wed, 05 Aug 2026 20:24:59 GMTTour Femmes: Reusser wins dramatic stage 4 ITT that sets up GC intrigue - Escape CollectiveEscape Collective · Tue, 04 Aug 2026 16:15:03 GMT